BioNTech is a biotechnology company based in Germany, primarily known for its work in developing immunotherapies for cancer and infectious diseases. Founded in 2008, the company gained significant prominence for its role in creating one of the first effective COVID-19 vaccines, developed in partnership with Pfizer. BioNTech specializes in harnessing the body’s immune system to create targeted therapies and vaccines, using messenger RNA (mRNA) technology as a platform for creating vaccines that can instruct cells to produce proteins that trigger an immune response. The success of its COVID-19 vaccine has positioned BioNTech as a leader in the biotechnology field, with ongoing research aimed at expanding its portfolio to include various therapeutic areas.
BioNTech is shifting focus from its COVID-19 vaccine success to mRNA-based cancer therapies, aiming for market approvals by 2026. The fourth quarter of 2024 saw BioNTech's earnings and revenue decline,…